Pulpotomy vs Root Canal Treatment for Teeth With Symptomatic Irreversible Pulpitis
Launched by NATIONAL UNIVERSITY HOSPITAL, SINGAPORE · Jul 19, 2023
Trial Information
Current as of July 23, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Mature permanent teeth with deep caries/restorations and symptoms indicative of irreversible pulpitis (moderate to severe spontaneous lingering pain) will be included in the study. The teeth will be randomised to receive one of two treatments: RCT or complete pulpotomy (n=35 in each group).
Baseline clinical and radiographic data will be collected at the first visit. In addition, patients (or their guardians, if relevant) will be invited to complete the acceptability and willingness to pay questionnaires for health economics analysis at both the first visit and at 12 months from the date o...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients aged 12 years or older
- • Mature permanent tooth with deep caries/restorations
- • Symptoms indicative of irreversible pulpitis (moderate to severe spontaneous lingering pain)
- • Tooth is responsive to cold and electric pulp test (EPT) sensibility testing
- • Tooth is restorable and can be adequately isolated during treatment
- • One tooth (molar or premolar) per patient.
- Exclusion Criteria:
- • Teeth with active periodontal disease (pocket depth \>5mm)
- • Teeth indicated for elective root canal treatment for restorative purposes
- • Teeth with apical periodontitis
- • Patients with complex medical histories that may affect their caries experience and healing ability (immunocompromised, radiotherapy etc.)
- • Patients who are unable to consent
- • History of trauma to the tooth
- • Presence of apical radiolucency
- • Patients who are pregnant or breast-feeding
- • Teeth with any evidence of purulence or excessive bleeding that cannot be controlled with a cotton pellet with 2-4% hypochlorite for 10 minutes
About National University Hospital, Singapore
National University Hospital (NUH) in Singapore is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, NUH emphasizes a multidisciplinary approach, integrating cutting-edge medical research with high-quality patient care. The hospital collaborates with various stakeholders, including academic institutions and industry partners, to explore new therapies and improve treatment outcomes across a wide range of medical disciplines. Committed to ethical standards and patient safety, NUH plays a pivotal role in shaping the future of medicine in Singapore and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Singapore, , Singapore
Patients applied
Trial Officials
Victoria Yu, PhD
Principal Investigator
National University Hosptial, Singapore
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported